First overall survival (OS) results from Arm A1 of the Phase 2 EDGE-Gastric study will be presented on October 18 at the European Society for Medical Oncology (ESMO) 2025 Congress These data support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results